Gopika SenthilKumar

Gopika SenthilKumar

Auto-generated profile, based on publicly available information

Gopika SenthilKumar

Medical Scientist Training Program, Medical College of Wisconsin, Milwaukee, Wisconsin

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2020 in Cancers
Verified
Journal Article
Open access
PDF file
RSRachel A. Schlaak
Rachel A. Schlaak
GSGopika SenthilKumar
Gopika SenthilKumar
MBMarjan Boerma
Marjan Boerma
CBCarmen Bergom
Carmen Bergom
Radiation therapy (RT) is an important component of cancer therapy, with >50% of cancer patients receiving RT. As the number of cancer survivors increases, the short- and long-term side effects of cancer therapy are of growing concern. Side effects of RT for thoracic tumors, notably cardiac and pulmonary toxicities, can cause morbidity and mortality in long-term cancer survivors. An understanding of the biological pathways and mechanisms involved in normal tissue toxicity from RT will improve future cancer treatments by reducing the risk of long-term side effects. Many of these mechanistic studies are performed in animal models of radiation exposure. In this area of research, the use of small animal image-guided RT with treatment planning systems that allow more accurate dose determination has the potential to revolutionize knowledge of clinically relevant tumor and normal tissue radiobiology. However, there are still a number of challenges to overcome to optimize such radiation delivery, including dose verification and calibration, determination of doses received by adjacent normal tissues that can affect outcomes, and motion management and identifying variation in doses due to animal heterogeneity. In addition, recent studies have begun to determine how animal strain and sex affect normal tissue radiation injuries. This review article discusses the known and potential benefits and caveats of newer technologies and methods used for small animal radiation delivery, as well as how the choice of animal models, including variables such as species, strain, and age, can alter the severity of cardiac radiation toxicities and impact their clinical relevance.

1 October 2023 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
GSGopika SenthilKumar
Gopika SenthilKumar
NMNatalia M. Mathieu
Natalia M. Mathieu
JFJulie K. Freed
Julie K. Freed
CSCurt D. Sigmund
Curt D. Sigmund
DGDavid Gutterman
David Gutterman
At the American Physiology Summit 2023 session entitled, “Mental Health for Graduate Students,” numerous students expressed struggling with poor mental well-being primarily because of negative experiences during their graduate training. In fact, studies show that up to 50% of graduate students report symptoms of depression, anxiety, or burnout during their training, and poor mental well-being is a major contributor to students’ decision to leave academia. Most of the current solutions focus on treatment or wellness strategies; while these are important and necessary, the training environment or culture that often contributes to worsening well-being continues to persist. In this collaborative article between trainees and mentors across various career stages, we discuss how the pace of scientific advancements and the associated competition, lack of sufficient support for students from diverse backgrounds, and mentor-mentee relationships crucially influence graduate students’ mental well-being. We then offer specific solutions at the individual, institutional, and national levels that can serve as a starting point for improving graduate students’ mental health and overall training experience.

1 September 2022 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
RBRadek Buss
Radek Buss
GSGopika SenthilKumar
Gopika SenthilKumar
MBMegan Bouchard
Megan Bouchard
ABAlexis Bowder
Alexis Bowder
JMJohn Marquart
John Marquart
Kyle Van ArendonkKyle Van Arendonk
Kyle Van Arendonk

1 August 2024 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
GSGopika SenthilKumar
Gopika SenthilKumar
ZZZachary Zirgibel
Zachary Zirgibel
KCKatie E. Cohen
Katie E. Cohen
BKBoran Katunaric
Boran Katunaric
AJAlyssa M. Jobe
Alyssa M. Jobe
JFJulie K. Freed
Julie K. Freed
Ceramides, a group of biologically active sphingolipids, have been described as the new cholesterol given strong evidence linking high plasma ceramide with endothelial damage, risk for early adverse cardiovascular events, and development of cardiometabolic disease. This relationship has sparked great interest in investigating therapeutic targets with the goal of suppressing ceramide formation. However, the growing data challenge this paradigm of ceramide as solely eliciting detrimental effects to the cardiovascular system. Studies show that ceramides are necessary for maintaining proper endothelial redox states, mechanosensation, and membrane integrity. Recent work in preclinical models and isolated human microvessels highlights that the loss of ceramide formation can in fact propagate vascular endothelial dysfunction. Here, we delve into these conflicting findings to evaluate how ceramide may be capable of exerting both beneficial and damaging effects within the vascular endothelium. We propose a unifying theory that while basal levels of ceramide in response to physiological stimuli are required for the production of vasoprotective metabolites such as S1P (sphingosine-1-phosphate), the chronic accumulation of ceramide can promote activation of pro-oxidative stress pathways in endothelial cells. Clinically, the evidence discussed here highlights the potential challenges associated with therapeutic suppression of ceramide formation as a means of reducing cardiovascular disease risk.

1 January 2022 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
KCKatie E. Cohen
Katie E. Cohen
BKBoran Katunaric
Boran Katunaric
GSGopika SenthilKumar
Gopika SenthilKumar
JMJennifer Jury McIntosh
Jennifer Jury McIntosh
JFJulie K. Freed
Julie K. Freed
Cardiovascular disease risk increases with age regardless of sex. Some of this risk is attributable to alterations in natural hormones throughout the life span. The quintessential example of this being the dramatic increase in cardiovascular disease following the transition to menopause. Plasma levels of adiponectin, a “cardioprotective” adipokine released primarily by adipose tissue and regulated by hormones, also fluctuate throughout one’s life. Plasma adiponectin levels increase with age in both men and women, with higher levels in both pre- and postmenopausal women compared with men. Younger cohorts seem to confer cardioprotective benefits from increased adiponectin levels yet elevated levels in the elderly and those with existing heart disease are associated with poor cardiovascular outcomes. Here, we review the most recent data regarding adiponectin signaling in the vasculature, highlight the differences observed between the sexes, and shed light on the apparent paradox regarding increased cardiovascular disease risk despite rising plasma adiponectin levels over time.

5 January 2024 in Circulation Research
Verified
Journal Article
Open access
GSGopika SenthilKumar
Gopika SenthilKumar
BKBoran Katunaric
Boran Katunaric
ZZZachary Zirgibel
Zachary Zirgibel
BLBrian Lindemer
Brian Lindemer
MJMaria J. Jaramillo-Torres
Maria J. Jaramillo-Torres
JFJulie K. Freed
Julie K. Freed
Background: Elevated plasma ceramides and microvascular dysfunction both independently predict adverse cardiac events. Despite the known detrimental effects of ceramide on the microvasculature, evidence suggests that activation of the shear-sensitive, ceramide-forming enzyme NSmase (neutral sphingomyelinase) elicits formation of vasoprotective nitric oxide (NO). Here, we explore a novel hypothesis that acute ceramide formation through NSmase is necessary for maintaining NO signaling within the human microvascular endothelium. We further define the mechanism through which ceramide exerts beneficial effects and discern key mechanistic differences between arterioles from otherwise healthy adults (non–coronary artery disease [CAD]) and patients diagnosed with CAD. Methods: Human arterioles were dissected from discarded surgical adipose tissue (n=166), and vascular reactivity to flow and C2-ceramide was assessed. Shear-induced NO and mitochondrial hydrogen peroxide (H 2 O 2 ) production were measured in arterioles using fluorescence microscopy. H 2 O 2 fluorescence was assessed in isolated human umbilical vein endothelial cells. Results: Inhibition of NSmase in arterioles from otherwise healthy adults induced a switch from NO to NOX-2 (NADPH-oxidase 2)–dependent H 2 O 2 -mediated flow-induced dilation. Endothelial dysfunction was prevented by treatment with sphingosine-1-phosphate (S1P) and partially prevented by C2-ceramide and an agonist of S1P-receptor 1 (S1PR1); the inhibition of the S1P/S1PR1 signaling axis induced endothelial dysfunction via NOX-2. Ceramide increased NO production in arterioles from non-CAD adults, an effect that was diminished with inhibition of S1P/S1PR1/S1P-receptor 3 signaling. In arterioles from patients with CAD, inhibition of NSmase impaired the overall ability to induce mitochondrial H 2 O 2 production and subsequently dilate to flow, an effect not restored with exogenous S1P. Acute ceramide administration to arterioles from patients with CAD promoted H 2 O 2 as opposed to NO production, an effect dependent on S1P-receptor 3 signaling. Conclusion: These data suggest that despite differential downstream signaling between health and disease, NSmase-mediated ceramide formation is necessary for proper functioning of the human microvascular endothelium. Therapeutic strategies that aim to significantly lower ceramide formation may prove detrimental to the microvasculature.